Ann GidnerCEO at ZiccumSpeaker
Profile
Ann Gidner, CEO of Ziccum AB, has +25 years in international Life Science Management. She served as CEO of SelectImmune Pharma AB, AcuCort AB, and Monocl AB. Ms Gidner was Business Unit Head of Inceptua Clinical trials in Germany and Licensing Director at Novozymes in Denmark. She held senior Global Business Director roles at large CDMO organizations; Cambrex Corporation in New Jersey, US and Lanxess GmbH in Germany. She has been a Board Director of several Swedish Biotech companies. She holds an MSc in Bioprocessing Engineering from LTH Sweden + French Elite University ENSIGCT, an MBA, and a French Diploma, Sorbonne, Paris.
Agenda Sessions
Enabling the Full Potential of mRNA - With Robust, Particle Engineered, Thermostable Dry Product Forms
, 4:00pmView Session